PARNAX LAB
Back to Balance Sheet
|
PARNAX LAB Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹32 Cr | ₹35 Cr | ₹20 Cr | ₹24 Cr | ₹19 Cr |
What is the latest Total Non-Current Liabilities ratio of PARNAX LAB ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹35 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹24 Cr |
| Mar2021 | ₹19 Cr |
How is Total Non-Current Liabilities of PARNAX LAB Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | -8.50 | |
| Mar2024 | ₹35 Cr | 78.25 | |
| Mar2023 | ₹20 Cr | -18.33 | |
| Mar2022 | ₹24 Cr | 25.66 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Non-Current Liabilities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹141.5 Cr | -2% | 10.4% | 14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | -2% |
10.4% |
14% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses